Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrous Oxide in Treatment-Resistant Bipolar Depression
NCT02757521Phase 1Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Mar 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in bipolar disorder (BD) comparing Placebo with Nitrous Oxide (2 arms). Primary endpoint: Montgomery Asberg Depression Rating Scale at 1 week. Started Mar 2016; status: terminated.
02
Drugs
nitrous oxide
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02757521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02757521.